Is age associated with the number or types of medications prescribed to renal transplant recipients?

Journal of the American Geriatrics Society

Volumn 55, Issue 3, 2007, Pages 389-394

  Chisholm, Marie A ^a,b   Melroy, Joel ^a   Johnson, Maribeth ^b   Mulloy, Laura L ^b   Spivey, Christina A ^a  

^a UNIVERSITY OF GEORGIA   (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Aging; Medication regimens; Renal transplantation

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; AZATHIOPRINE; CYCLOSPORIN; MYCOPHENOLIC ACID; PREDNISONE; RAPAMYCIN; TACROLIMUS;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEMOGRAPHY; DRUG BLOOD LEVEL; FEMALE; GLUCOSE BLOOD LEVEL; HOSPITALIZATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; RANDOM SAMPLE; RECIPIENT; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 33847295210     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2007.01077.x     Document Type: Article

References (43)

1. Organ Procurement and Transplantation Network. Transplants in the U.S. by Recipient's Age [on-line]. Available at www.optn.org/latestData/rptData.asp Accessed February 15, 2006.
2. American Diabetes Association. Complications of Diabetes in the United States [on-line]. Available at www.diabetes.org/diabetes-statistics/ complications.jsp Accessed February 15, 2006.
3. National Kidney and Urologic Disease Information Clearinghouse. Kidney and Urologic Disease Statistics for the United States [on-line]. National Institutes of Health. Available at http://kidney.niddk.nih.gov/kudiseases/pubs/ kustats/index.htm Accessed February 16, 2006.
4. Lo A, Ryder K, Shorr R. Relationship between patient age and duration of physician visit in ambulatory setting. Does one size fit all? J Am Geriatr Soc 2005;53:1162-1167.
5. Rathore S, Mehta S, Boyko W et al. Prescription medication use in older Americans: A national report card on prescribing. Fam Med 1998;30:733-739.
6. Jainkittivong A, Aneksuk V, Langlais R. Medical health and medication use in elderly dental patients. J Contemp Dent Pract 2004;5:1-10.
7. Health, United States, 2005. Hyattsville, MD: U.S. Department of Health and Human Services, 2005.
8. Geriatrics: Overview. Available at http://www.globalrph.com/ geriatricoverview.htm Accessed February 16, 2006.
9. Roth M, Ivey J. Self-reported medication use in community-residing older adults: A pilot study. J Am Geriatr Pharmacother 2005;3:196-204.
10. Barat I, Andreasen F, Damsgaard E. Drug therapy in the elderly: What doctors believe and patients actually do. Br J Clin Pharmacol 2001;51:615-622.
11. Chia L, Schlenk E, Dunbar-Jacob J. Effect of personal and cultural beliefs on medication adherence in the elderly. Drugs Aging 2006;23:191-202.
12. Fu A, Liu G, Christensen D. Inappropriate medication use and health outcomes in the elderly. J Am Geriatr Soc 2004;52:1934-1939.
13. Maio V, Goldfarb N, Sikirika V et al. The Need for Choice of Medicines in Formularies for the Elderly: A Clinical Review of Three Common Therapeutic Classes. Philadelphia, PA: Department of Health Policy, Jefferson Medical College, 2004.
14. Beers M. Explicit criteria for determining potentially inappropriate medication use by the elderly: An update. Arch Intern Med 1997;157:1531-1536.
15. Mangoni A, Jackson S. Age-related changes in pharmacokinetics and pharmacodynamics. Basic principles and practical applications. Br J Clin Pharmacol 2004;57:6-14.
16. ChisholmM, Bagby T, DiPiro J et al. Cost analysis of renal transplant recipients' medication 1-year post-transplantation. Pharmacotherapy 1998;18:1174.
17. Pirsch J. Care of the transplant patient. Clin Symposia 1998;50:2-35.
18. National Cholesterol Education Program. Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Bethesda, MD: National Institutes of Health, National Heart, Lung, and Blood Institute, 2002.
19. National High Blood Pressure Education Program. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Bethesda, MD: National Institutes of Health, National Heart, Lung, and Blood Institute, 2004.
20. Kasiske BL, Snyder J, Gilberson D et al. Diabetes mellitus after kidney transplantation in the United States. Am J Transplant 2003;3:178-185.
21. Cosio FG, Pesavento T, Osei K et al. Post-transplant diabetes mellitus: Increasing incidence in renal allograft recipients transplanted in recent years. Kidney Int 2001;59:732-737.
22. Borzecki A, Glickman M, Kader B et al. The effect of age on hypertension control and management. Am J Hypertens 2006;19:520-527.
23. Racusen LC, Solez K, Colvin RB et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999;55:713-723.
24. Racusen LC, Colvin RB, Solez K et al. Antibody-mediated rejection criteriaFan addition to the Banff 097 classification of renal allograft rejection. Am J Transplant 2003;3:708-714.
25. United States Renal Data System. Am J Kidney Dis 2003;42(6 Part 6):1-230.
26. American Diabetes Association. Total prevalence of diabetes and pre-diabetes. Available at http://www.diabetes.org/diabestes-statistics/ prevalence.jsp Accessed February 15, 2006.
27. Araki M, Flechner SM, Ismail HR et al. Posttransplant diabetes mellitus in kidney transplant recipients receiving calcineurin or mTOR inhibitor drugs. Transplantation 2006;81:335-341.
28. Gourishankar S, Jhangri G, Tonelli M et al. Development of diabetes mellitus after kidney transplantation: A Canadian experience. Am J Transplant 2004;4:1876-1882.
29. Schiel R, Heinrich S, Steiner T et al. Post-transplant diabetes mellitus: Risk factors, frequency of transplant rejections, and long-term prognosis. Clin Exp Nephrol 2005;9:164-169.
30. Cosio FG, Kudva Y, van der Velde M et al. New onset hyperglycemia and diabetes are associated with increased cardiovascular risk after kidney transplantation. Kidney Int 2005;67:2415-2421.
31. Revanur V, Jardine A, Kingsmore D et al. Influence of diabetes mellitus on patient and graft survival in recipients of kidney transplantation. Clin Transplant 2001;15:89-94.
32. Cosio FG, Pesavento T, Kim S et al. Patient survival after renal transplantation. IV. Impact of post-transplant diabetes. Kidney Int 2002;62:1440-1446.
33. Nampoory M, Johny K, Costandi J et al. Inferior long-term outcome of renal transplantation in patients with diabetes mellitus. Med Princ Pract 2002;11:29-34.
34. Tutone V, Mark P, Stewart G et al. Hypertension, antihypertensive agents, and outcomes following renal transplantation. Clin Transplant 2005;19:181-192.
35. Opelz G, Dohler B. Improved long-term outcomes after renal transplantation associated with blood pressure control. Am J Transplant 2005;5:2725-2731.
36. Joosten S, Sijpkens Y, van Kooten C et al. Chronic renal allograft rejection: pathophysiologic considerations. Kidney Int 2005;68:1-13.
37. Kasiske BL, Snyder J. Matching older kidneys with older patients does not improve allograft survival. J Am Soc Nephrol 2002;13:1067-1072.
38. Massy ZA, Guijarro C, Wiederkehr MR et al. Chronic renal allograft rejection: Immunologic and nonimmunologic risk factors. Kidney Int 1996;49:518-524.
39. Meier-Kriesche HU, Kaplan B. Immunosuppression in elderly real transplant recipients: Are current regimens too aggressive? Drugs Aging 2001;18:751-759.
40. Meier-Kriesche HU, Ojo A, Hanson J et al. Increased immunosuppressive vulnerability in elderly renal transplant recipients. Transplantation 2000;69:885-889.
41. Friedman AL, Goker O, Kalish MAet al. Renal transplant recipients over aged 60 have diminished immune activity and a low risk of rejection. Int Urol Nephrol 2004;36:451-456.
42. Renal Replacement Therapy. The Nephrology Channel [on-line]. Available at www.nephrologychannel.com/rrt/transplant.shtml Accessed September 19, 2006.
43. Meier-Kriesche HU, Friedman G, Jacobs M et al. Infectious complications in geriatric renal transplant patients: Comparison of two immunosuppressive protocols. Transplantation 1999;68:1496-1502.